P's study’s main goal was to provide indications of efficacy, safety and tolerability upon treating patients with mild to moderate plaque psoriasis via oral delivery. It's not that they were trying to get the right dose. They were testing the oral dosing method for indications of efficacy and safety. They saw a response! Now they know they can increase without safety or side effect concerns.
News 
Market Data 
Discover 
